RNS Number : 2280Q
Stenprop Limited
17 June 2020
STENPROP LIMITED
(Registered in Guernsey)
(Registration number 64865)
LSE share code: STP JSE share code: STP
ISIN: GG00BFWMR296
("Stenprop" or the "Company")
DEALINGS IN SECURITIES BY DIRECTORS AND BY THE COMPANY SECRETARY
17 June 2020
Shareholders are advised of the following information relating to the acceptance of nil cost options and market value options awarded on 12 June 2020 under the Stenprop Limited Long-Term Incentive Plan (the "LTIP"). The nil cost options will vest on 12 June 2023 subject to certain vesting conditions having been met, including performance targets set by the remuneration committee prior to the awards being made. Assuming that the performance targets are met in full at the end of the performance period, the nil cost options will result in the issue of 1,052,230 shares. The market value options will vest in three tranches on 31 March 2021, 31 March 2022 and 31 March 2023 and once fully vested will result in the issue of 182,375 shares subject to the payment of the exercise price of £1.0492 per share.
Name of director: | Paul Arenson |
Transaction date: | 12 June 2020 |
Class of securities: | Nil cost options |
Number of securities: | 536,599 |
Nature of transaction | Off-market acceptance of nil cost options in terms of the LTIP |
Nature and extent of director's interest: | Direct beneficial |
Clearance to deal received: | Yes |
Name of director: | Julian Carey |
Transaction date: | 12 June 2020 |
Class of securities: | Nil cost options |
Number of securities: | 515,631 |
Nature of transaction: | Off-market acceptance of nil cost options in terms of the LTIP |
Nature and extent of director's interest: | Direct beneficial |
Clearance to deal received: | Yes |
Name of director: | James Beaumont |
Transaction date: | 12 June 2020 |
Class of securities: | Market value options |
Number of securities: | 102,932 |
Total price payable on exercise: | £107,996.25 |
Nature of transaction: | Off-market acceptance of market value options in terms of the LTIP |
Nature and extent of director's interest: | Direct beneficial |
Clearance to deal received: | Yes |
Name of company secretary: | Sarah Bellilchi |
Transaction date: | 12 June 2020 |
Class of securities: | Market value options |
Number of securities: | 79,443 |
Total price payable on exercise: | £83,351.60 |
Nature of transaction: | Off-market acceptance of market value options in terms of the LTIP |
Nature and extent of company secretary's interest: | Direct beneficial |
Clearance to deal received: | Yes |
Shareholders are further advised of the following information relating to the acceptance of nil cost options awarded on 12 June 2020 under the Stenprop Limited Deferred Bonus Plan (the "DBP"). One third of these nil cost options vested immediately, with the second third vesting on 31 March 2021 and the last third vesting on 31 March 2022. Once fully vested, they will result in the issue of 71,124 shares.
Name of director: | Paul Arenson |
Transaction date: | 12 June 2020 |
Class of securities: | Nil cost options |
Number of securities: | 29,712 |
Nature of transaction: | Off-market acceptance of nil cost options in terms of the DBP |
Nature and extent of director's interest: | Direct beneficial |
Clearance to deal received: | Yes |
Name of director: | Julian Carey |
Transaction date: | 12 June 2020 |
Class of securities: | Nil cost options |
Number of securities: | 28,558 |
Nature of transaction: | Off-market acceptance of nil cost options in terms of the DBP |
Nature and extent of director's interest: | Direct beneficial |
Clearance to deal received: | Yes |
Name of director: | James Beaumont |
Transaction date: | 12 June 2020 |
Class of securities: | Nil cost options |
Number of securities: | 9,768 |
Nature of transaction: | Off-market acceptance of nil cost options in terms of the DBP |
Nature and extent of director's interest: | Direct beneficial |
Clearance to deal received: | Yes |
Name of company secretary: | Sarah Bellilchi |
Transaction date: | 12 June 2020 |
Class of securities: | Nil cost options |
Number of securities: | 3,086 |
Nature of transaction: | Off-market acceptance of nil cost options in terms of the DBP |
Nature and extent of director's interest: | Direct beneficial |
Clearance to deal received: | Yes |
For further information:
Stenprop Limited 44(0)20 3918 6600
Paul Arenson (paul.arenson@stenprop.com)
Julian Carey (julian.carey@stenprop.com)
James Beaumont (james.beaumont@stenprop.com)
Numis Securities Limited (Financial Adviser) 44(0)20 7260 1000
Hugh Jonathan
Vicki Paine
Justin Bell
FTI Consulting 44(0)20 3727 1000
Richard Sunderland stenprop@fticonsulting.com
Richard Gotla
Indraneel Bose
Java Capital Trustees and Sponsors Proprietary Limited 27 (0)11 722 3050
(JSE Sponsor)
About Stenprop:
Stenprop is a UK REIT listed on the LSE and the JSE. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to stenprop.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.